Literature DB >> 1629497

Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation.

P W van der Linden1, C E Hack, J Poortman, Y C Vivié-Kipp, A Struyvenberg, J K van der Zwan.   

Abstract

One hundred thirty-eight patients with a previous anaphylactic reaction to a yellow jacket or a honeybee sting, as well as eight volunteers, were subjected to an in-hospital sting challenge. Plasma levels of histamine, tryptase, and prostaglandin D2 (PGD2) during sting challenge were studied in relation to clinical symptoms. Prechallenge levels (mean +/- SD) of histamine, tryptase, and PGD2 were 2 +/- 1 nmol/L, 0.3 +/- 0.3 U/L, and 320 +/- 223 ng/L, respectively. In the volunteers and in none except for one of the nonreacting patients, these levels did not change significantly after challenge. In contrast, mean increases in the group of 18 patients with a mild reaction were significant for histamine and tryptase at one or more time points after the challenge. (Five patients demonstrated no increase in histamine; nine demonstrated no increase in tryptase.) Except for histamine levels in one patient, these increases were considerably more in all 17 patients with a severe reaction, starting from the first anaphylactic symptoms. Fifteen minutes later, peak values were reached of 1275 +/- 2994 nmol of histamine per liter (range, 3 to 12800 nmol/L; median, 11 nmol/L) and 406 +/- 1062 U of tryptase per liter (range, 1.8 to 4400 U/L; median, 17 U/L). This rise in levels inversely correlated with the mean arterial pressure. Plasma levels of PGD2 in severely reacting patients did not differ significantly from those in patients with a mild or no reaction. In conclusion, only 28% of patients with a history of Hymenoptera anaphylaxis developed an anaphylactic reaction after an in-hospital challenge.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629497     DOI: 10.1016/s0091-6749(06)80017-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  23 in total

Review 1.  Tryptase genetics and anaphylaxis.

Authors:  George H Caughey
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

Review 2.  Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Authors:  A Matito; I Alvarez-Twose; J M Morgado; L Sánchez-Muñoz; A Orfao; L Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

Review 3.  Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations.

Authors:  Paneez Khoury; Jonathan J Lyons
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-27       Impact factor: 4.806

4.  Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Authors:  L B Schwartz; T R Bradford; C Rouse; A M Irani; G Rasp; J K Van der Zwan; P W Van der Linden
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

5.  Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.

Authors:  I Alvarez-Twose; S Vañó-Galván; L Sánchez-Muñoz; J M Morgado; A Matito; A Torrelo; P Jaén; L B Schwartz; A Orfao; L Escribano
Journal:  Allergy       Date:  2012-03-28       Impact factor: 13.146

Review 6.  The pathophysiology of anaphylaxis.

Authors:  Laurent L Reber; Joseph D Hernandez; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2017-08       Impact factor: 10.793

7.  The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.

Authors:  L B Schwartz; K Sakai; T R Bradford; S Ren; B Zweiman; A S Worobec; D D Metcalfe
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 8.  Practical guidelines for the response to perioperative anaphylaxis.

Authors:  Tomonori Takazawa; Ken Yamaura; Tetsuya Hara; Tomoko Yorozu; Hiromasa Mitsuhata; Hiroshi Morimatsu
Journal:  J Anesth       Date:  2021-10-14       Impact factor: 2.078

Review 9.  Food-Induced Anaphylaxis: an Update.

Authors:  Christopher P Parrish; Heidi Kim
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-14       Impact factor: 4.806

10.  Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation.

Authors:  S G A Brown; K E Blackman; V Stenlake; R J Heddle
Journal:  Emerg Med J       Date:  2004-03       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.